Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jgrant@smith.edu
    Junior Member
    • Mar 2015
    • 3

    #1

    Spiked-in control for microbiome

    Hello! I am helping out with a microbiome project and my collaborators have had a problem that can best be explained by a sample naming error at the sequencing facility. They have agreed to resequence our samples but we have lost some faith! We would like to add an internal control to some samples to be able to distinguish them. I am thinking of adding some genomic bacterial DNA that would not be found on our environment to some, but not all, of the samples.

    My question is technical. I wonder how much to add, and if adding a known amount of DNA to our environmental samples can affect the results in any way. I couldn't find any protocol for spiking environmental samples with bacteria for this purpose.

    Any advice on what to use and how much to add would be much appreciated!
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    I suggest using custom synthetic oligos for spiking that could not possibly compromise your results. ~1% should be good, though it depends on how many reads you are expecting per library.

    Can you give a little more information about the degree of multiplexing, number of reads expected per library, and so forth? And given that this is 16S, do you need to spike in bacterial DNA to match the amplification primers, or are you sending them already-amplified samples, in which case you could spike in something else?

    Comment

    • jgrant@smith.edu
      Junior Member
      • Mar 2015
      • 3

      #3
      Thanks, Brian! We are providing DNA extractions to the sequencing facility, so I would want to add something that would be amplified by their 16S primers. But, I could create some synthetic oligo that includes the primer sites. The facility guarantees 10,000 reads per sample, with a target of 15,000. For the first round of sequencing we received anywhere from 8,000-25,000 reads. I am not sure about the degree of multiplexing, but I would guess high given how few (relatively) reads per sample we are aiming for.

      Comment

      • Brian Bushnell
        Super Moderator
        • Jan 2014
        • 2709

        #4
        If you create some synthetic oligos, you could standardize on spiking them into everything with no worries about incurring analysis problems, since they'll be very easy to remove, and that will make it easier to quantify, which allows checking for cross-contamination in addition to sample mixups. It could even improve your sequence quality by increasing color diversity (though that's hardly the goal, or an expected outcome at such a low level of spiking). For 10k reads 1% should be sufficient, at least to find sample mixups, if not low-level cross-contamination. Normally when we spike tracer sequences into a plate, only half the wells get it and the other half don't, to save on the number of unique sequences needed. Though you don't really need a unique sequence for each well; statistically, you'll be able to detect most major problems with a handful of different sequences.

        Comment

        • thermophile
          Senior Member
          • Apr 2015
          • 243

          #5
          Have you heard an adequate explanation for what happened that leads you to believe that it wouldn't happen again? Do you know how long it will take to get your new data back? I'd want those questions answered before sending more samples.

          But for your question, rather than getting synthetic DNA made, I'd add some extra control samples (pure cultures or defined communities).
          Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-06-2026, 07:41 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          39 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          43 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Working...